Study to Assess the Efficacy and Safety of Orismilast in Atopic Dermatitis (ADESOS)

NCT05469464 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

235

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis
Skin Diseases

Interventions

DRUG: Orismilast modified release tablets
DRUG: Placebo

Sponsor

UNION therapeutics